Quantitative PCR Pitfalls: The Case of the Human Placenta

• DOI: 10.1007/s12033-012-9539-2
• Publication Date: 2012-04-16T07:49:42Z
• Authors: Dave Lanoix; Andrée-Anne Lacasse; Joey St-Pierre; Sean C. Taylor; Maude Ethier-Chia...; Julie Lafond; Cathy Vaillancourt
• Keywords: Adult; Male; Quality Control; Placenta; 610; Gene Expression; Guidelines as Topic; -; Real-Time Polymerase Chain Reaction; DNA Glycosylases; Specimen Handling; 03 medical and health sciences; Pre-Eclampsia; Pregnancy; Humans; 0303 health sciences; Reverse Transcriptase Polymerase Chain Reaction; Gene Expression Profiling; Sequence Analysis, DNA; Reference Standards; 3. Good health; Diabetes, Gestational; Research Design; RNA; Female

Reverse-transcription quantitative polymerase chain reaction (RT-qPCR) is a rapid and high throughput gene expression quantification technology. In order to obtain accurate results, several key experimental design and standardization steps must be rigorously followed as previously described in the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines. This study investigates the effect of reference gene normalization and the impact of RNA degradation on gene expression of 8-oxoguanine DNA glycosylase in human placenta from pregnancies complicated by preeclampsia and gestational diabetes mellitus and their gestation-matched controls. The data presented here show how RNA quality and appropriate reference gene selection is not only important to obtain accurate and reproducible RT-qPCR data but how different and even opposite results can be reported if the key steps outlined in the MIQE guidelines are not followed. The procedures and associated results presented in this study provide the first practical application of the MIQE guidelines to placental analysis in normal and pathological pregnancies.